2020•Unpublished venueRequires access

Adenoviral Delivery of Matrix Metalloproteinase 3 (MMP3)-Directed Tissue Inhibitor of Metalloproteinase 1 (TIMP1) Variants Ameliorates Fibrosis Established by Transforming Growth Factor Beta (TGFB) or Bleomycin in Mice

Melody Stallings‐Mann, Maryam Raeeszadeh‐Sarmazdeh, Erin Miller, Evette S. Radisky, Derek C. Radisky

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: TIMP1, MMP3, Matrix metalloproteinase, Metalloproteinase, Tissue inhibitor of metalloproteinase, Transforming growth factor beta, Cancer research, Bleomycin

Back to paper search Browse research topics Original source

Adenoviral Delivery of Matrix Metalloproteinase 3 (MMP3)-Directed Tissue Inhibitor of Metalloproteinase 1 (TIMP1) Variants Ameliorates Fibrosis Established by Transforming Growth Factor Beta (TGFB) or Bleomycin in Mice — Research Paper | ScholarLens